Whesley Tanor Silva, Mauro Felippe Felix Mediano, Lucas Frois Fernandes de Oliveira, Keity Lamary Souza Silva, Matheus Ribeiro Ávila, Thaís Souza Azevedo, Marcus Alessandro de Alcantara, Alessandra de Carvalho Bastone, Renato Guilherme Trede Filho, Vanessa Pereira Lima, Ana Cristina Rodrigues Lacerda, Vanessa Amaral Mendonça, Sanny Cristina de Castro Faria, Daniel Menezes Souza, Luciano Fonseca Lemos de Oliveira, Pedro Henrique Scheidt Figueiredo, Henrique Silveira Costa
Objective: Chagas disease can cause several complications, such as Chagas cardiomyopathy, the most severe clinical form of the disease. Chagas cardiomyopathy is complex and involves biological and psychosocial factors that can compromise health-related quality of life. However, it is necessary to establish interactions that significantly impact the health-related quality of life of this population. Therefore, we aimed to develop and present a theoretical model on the impact of Chagas cardiomyopathy on the health-related quality of life of patients.
Methods: This is a cross-sectional study with a multi-methodology approach. The model's development process relied on the findings of a systematic review of qualitative studies, as well as a qualitative study involving participants from original communities, conventional rural areas and urban centres. Patients diagnosed with Chagas cardiomyopathy were interviewed using a semistructured research script, and the sample size was determined by theoretical saturation. Ultimately, the model underwent evaluation and received approval from three specialists in Chagas cardiomyopathy.
Results: Patients experience many emotional conflicts, manifested by feelings of sadness, existential emptiness and anxiety. They have fears related to the course of the disease, the inability to care for the people they love, their suffering and that of the family caregivers, as well as the fear of invasive treatments and death. The model based on social determinants of health was created and presented three different levels of factors that impact patients' health-related quality of life. At the first and most external level are social, cultural and environmental conditions: absence from work, difficulties in accessing healthcare services, limited resources for specialised care and geographical barriers to accessing healthcare services. At a more internally committed level, there are social factors and community networks encompassing social isolation, family conflicts, social stigma, emotional aspects, fears and disabilities. The innermost layer of factors represents personal and behavioural complaints, such as physical ailments and poor sleep quality.
Conclusion: The factors that affect the health-related quality of life of patients with Chagas cardiomyopathy are diverse in their biopsychosocial nature.
{"title":"Health-related quality of life in Chagas cardiomyopathy: Development of a theoretical model.","authors":"Whesley Tanor Silva, Mauro Felippe Felix Mediano, Lucas Frois Fernandes de Oliveira, Keity Lamary Souza Silva, Matheus Ribeiro Ávila, Thaís Souza Azevedo, Marcus Alessandro de Alcantara, Alessandra de Carvalho Bastone, Renato Guilherme Trede Filho, Vanessa Pereira Lima, Ana Cristina Rodrigues Lacerda, Vanessa Amaral Mendonça, Sanny Cristina de Castro Faria, Daniel Menezes Souza, Luciano Fonseca Lemos de Oliveira, Pedro Henrique Scheidt Figueiredo, Henrique Silveira Costa","doi":"10.1111/tmi.14087","DOIUrl":"https://doi.org/10.1111/tmi.14087","url":null,"abstract":"<p><strong>Objective: </strong>Chagas disease can cause several complications, such as Chagas cardiomyopathy, the most severe clinical form of the disease. Chagas cardiomyopathy is complex and involves biological and psychosocial factors that can compromise health-related quality of life. However, it is necessary to establish interactions that significantly impact the health-related quality of life of this population. Therefore, we aimed to develop and present a theoretical model on the impact of Chagas cardiomyopathy on the health-related quality of life of patients.</p><p><strong>Methods: </strong>This is a cross-sectional study with a multi-methodology approach. The model's development process relied on the findings of a systematic review of qualitative studies, as well as a qualitative study involving participants from original communities, conventional rural areas and urban centres. Patients diagnosed with Chagas cardiomyopathy were interviewed using a semistructured research script, and the sample size was determined by theoretical saturation. Ultimately, the model underwent evaluation and received approval from three specialists in Chagas cardiomyopathy.</p><p><strong>Results: </strong>Patients experience many emotional conflicts, manifested by feelings of sadness, existential emptiness and anxiety. They have fears related to the course of the disease, the inability to care for the people they love, their suffering and that of the family caregivers, as well as the fear of invasive treatments and death. The model based on social determinants of health was created and presented three different levels of factors that impact patients' health-related quality of life. At the first and most external level are social, cultural and environmental conditions: absence from work, difficulties in accessing healthcare services, limited resources for specialised care and geographical barriers to accessing healthcare services. At a more internally committed level, there are social factors and community networks encompassing social isolation, family conflicts, social stigma, emotional aspects, fears and disabilities. The innermost layer of factors represents personal and behavioural complaints, such as physical ailments and poor sleep quality.</p><p><strong>Conclusion: </strong>The factors that affect the health-related quality of life of patients with Chagas cardiomyopathy are diverse in their biopsychosocial nature.</p>","PeriodicalId":23962,"journal":{"name":"Tropical Medicine & International Health","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143047941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katelyn E Flaherty, Mohammed-Najeeb Mahama, Molly B Klarman, Nana A Anane-Binfoh, Mayur D Patel, Nathaniel J Smith, Maxwell Osei-Ampofo, Michael Mathelier, Eric J Nelson, Ahmed N Zakariah, Taiba J Afaa, Torben K Becker
Background: The ADAPT guidance proposes a process model for adapting evidence-informed interventions to novel contexts. Herein, we leveraged this guidance to adapt a paediatric nighttime telemedicine and medication delivery service from Haiti, a setting with low malaria prevalence, to Ghana, where malaria is a leading cause of paediatric mortality.
Methods: Core components of the intervention were defined and conserved. Discretionary components were identified and considered for adaptation. The service was defined by a workflow involving a call from a guardian of a sick child, a telemedicine assessment, referral of severe cases, and medication delivery/in-person assessments for non-severe cases. Key adaptations related to partner organisation (private to public/government), clinician type (nurse to emergency medical technician), user fees (sliding scale to none), and point-of-care testing (none to malaria rapid diagnostic testing). The adapted model was implemented in Jamestown and Usshertown, Ghana, on 16 November 2022 as part of a 12-month study to evaluate implementation outcomes and the role of the telemedicine assessment. Empiric thresholds for safety and feasibility were set a priori and served as benchmarks for this study and points of iteration for future studies.
Results: In the first year of implementation, 517 cases were enrolled; 492 were included in the analysis, 96% of which were reached at 10-day follow-up. Safety and feasibility thresholds were met. 98% of febrile cases received rapid diagnostic testing for malaria; 4% tested positive. At 10 days, 97% of cases were improving/well, and no severe adverse events were reported. The median lengths of the telemedicine assessment, time to delivery, and in-person assessments were 9, 49, and 43 min, respectively. 99% of participants expressed interest in using the service again. There was fair congruence between paired telemedicine and in-person assessments for vital sign assessments and mild/moderate triage decisions.
Conclusions: A nighttime paediatric telemedicine and medication delivery service adapted and implemented per the ADAPT Guidance met a priori-defined safety and feasibility metrics in the malaria-endemic country of Ghana. The role of telemedicine in assessing vital signs and informing mild versus moderate triage decisions may be limited.
Trial registration: This study was registered on Clinicaltrials.gov on 8/17/2022 (NCT05506683).
{"title":"Applying the ADAPT guidance to implement a telemedicine and medication delivery service in a malaria-endemic setting: A prospective cohort study.","authors":"Katelyn E Flaherty, Mohammed-Najeeb Mahama, Molly B Klarman, Nana A Anane-Binfoh, Mayur D Patel, Nathaniel J Smith, Maxwell Osei-Ampofo, Michael Mathelier, Eric J Nelson, Ahmed N Zakariah, Taiba J Afaa, Torben K Becker","doi":"10.1111/tmi.14081","DOIUrl":"https://doi.org/10.1111/tmi.14081","url":null,"abstract":"<p><strong>Background: </strong>The ADAPT guidance proposes a process model for adapting evidence-informed interventions to novel contexts. Herein, we leveraged this guidance to adapt a paediatric nighttime telemedicine and medication delivery service from Haiti, a setting with low malaria prevalence, to Ghana, where malaria is a leading cause of paediatric mortality.</p><p><strong>Methods: </strong>Core components of the intervention were defined and conserved. Discretionary components were identified and considered for adaptation. The service was defined by a workflow involving a call from a guardian of a sick child, a telemedicine assessment, referral of severe cases, and medication delivery/in-person assessments for non-severe cases. Key adaptations related to partner organisation (private to public/government), clinician type (nurse to emergency medical technician), user fees (sliding scale to none), and point-of-care testing (none to malaria rapid diagnostic testing). The adapted model was implemented in Jamestown and Usshertown, Ghana, on 16 November 2022 as part of a 12-month study to evaluate implementation outcomes and the role of the telemedicine assessment. Empiric thresholds for safety and feasibility were set a priori and served as benchmarks for this study and points of iteration for future studies.</p><p><strong>Results: </strong>In the first year of implementation, 517 cases were enrolled; 492 were included in the analysis, 96% of which were reached at 10-day follow-up. Safety and feasibility thresholds were met. 98% of febrile cases received rapid diagnostic testing for malaria; 4% tested positive. At 10 days, 97% of cases were improving/well, and no severe adverse events were reported. The median lengths of the telemedicine assessment, time to delivery, and in-person assessments were 9, 49, and 43 min, respectively. 99% of participants expressed interest in using the service again. There was fair congruence between paired telemedicine and in-person assessments for vital sign assessments and mild/moderate triage decisions.</p><p><strong>Conclusions: </strong>A nighttime paediatric telemedicine and medication delivery service adapted and implemented per the ADAPT Guidance met a priori-defined safety and feasibility metrics in the malaria-endemic country of Ghana. The role of telemedicine in assessing vital signs and informing mild versus moderate triage decisions may be limited.</p><p><strong>Trial registration: </strong>This study was registered on Clinicaltrials.gov on 8/17/2022 (NCT05506683).</p>","PeriodicalId":23962,"journal":{"name":"Tropical Medicine & International Health","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stephen Ohidor, Nicholas A Presley, Angelia M Sanders, Andrew W Nute, Tania A Gonzalez, Yak Yak Bol, Albino W Nyibong, Paul Weiss, James Niquette, E Kelly Callahan, Scott D Nash
Background: Trachoma is targeted by the World Health Organization (WHO) for elimination as a public health problem by 2030. Trachoma impact surveys using standardised methodology are recommended to monitor progress towards elimination and to determine eligibility for continued surgery, antibiotics, facial cleanliness, and environmental improvement (SAFE) interventions. From 2007 to 2015, four counties of Eastern Equatoria State, South Sudan, received three to five rounds of mass drug administration with antibiotics. A trachoma impact survey in 2015 indicated all four counties had trachomatous-inflammation follicular prevalence among children ages 1-9 years above the WHO elimination threshold (range 17.4%-47.6%). Based on these results, the recommended number of years of SAFE interventions were implemented and the counties were subsequently resurveyed.
Methods: Between 2021 and 2023, trachoma impact surveys were conducted in Budi, Kapoeta East, Kapoeta North, and Kapoeta South counties using a two-stage cluster sample design. Trained and certified graders examined participants for trachoma clinical signs using the WHO simplified grading system to estimate county-level prevalence.
Results: A total of 12,570 individuals from 3286 households in 116 survey clusters were examined for trachoma. Prevalence of trachomatous-inflammation follicular among children ages 1-9 years was 5.6% (95% confidence interval [CI]:3.7%-8.3%) in Kapoeta South, 7.4% (CI:5.1%-10.7%) in Budi, 12.3% (CI:7.8%-18.9%) in Kapoeta East, and 18.1% (CI:13.5%-24.0%) in Kapoeta North. Trachomatous inflammation-intense prevalence among children ages 1-9 years ranged from 0.4% (CI:0.2%-1.0%) in Kapoeta East to 2.1% (CI:1.4%-3.2%) in Kapoeta North, and trachomatous trichiasis in individuals ages ≥15 years ranged from 1.0% (CI:0.5%-2.1%) in Kapoeta North to 1.9% (CI:1.3%-2.8%) in Budi.
Conclusions: As no county reached the WHO elimination thresholds of trachomatous-inflammation follicular <5% or trachomatous trichiasis <0.2%, SAFE interventions should continue. Furthermore, these districts are classified as having persistent trachoma, based on trachomatous-inflammation follicular levels remaining >5% after two impact surveys. Compared to results from 2015, the prevalence of trachomatous-inflammation follicular, trachomatous inflammation-intense, and trachomatous trichiasis in all counties decreased, indicating that the Republic of South Sudan Ministry of Health's Trachoma Control Program is advancing towards its elimination goal.
{"title":"Progress towards the elimination of trachoma as a public health problem in four counties of Eastern Equatoria State, Republic of South Sudan.","authors":"Stephen Ohidor, Nicholas A Presley, Angelia M Sanders, Andrew W Nute, Tania A Gonzalez, Yak Yak Bol, Albino W Nyibong, Paul Weiss, James Niquette, E Kelly Callahan, Scott D Nash","doi":"10.1111/tmi.14078","DOIUrl":"https://doi.org/10.1111/tmi.14078","url":null,"abstract":"<p><strong>Background: </strong>Trachoma is targeted by the World Health Organization (WHO) for elimination as a public health problem by 2030. Trachoma impact surveys using standardised methodology are recommended to monitor progress towards elimination and to determine eligibility for continued surgery, antibiotics, facial cleanliness, and environmental improvement (SAFE) interventions. From 2007 to 2015, four counties of Eastern Equatoria State, South Sudan, received three to five rounds of mass drug administration with antibiotics. A trachoma impact survey in 2015 indicated all four counties had trachomatous-inflammation follicular prevalence among children ages 1-9 years above the WHO elimination threshold (range 17.4%-47.6%). Based on these results, the recommended number of years of SAFE interventions were implemented and the counties were subsequently resurveyed.</p><p><strong>Methods: </strong>Between 2021 and 2023, trachoma impact surveys were conducted in Budi, Kapoeta East, Kapoeta North, and Kapoeta South counties using a two-stage cluster sample design. Trained and certified graders examined participants for trachoma clinical signs using the WHO simplified grading system to estimate county-level prevalence.</p><p><strong>Results: </strong>A total of 12,570 individuals from 3286 households in 116 survey clusters were examined for trachoma. Prevalence of trachomatous-inflammation follicular among children ages 1-9 years was 5.6% (95% confidence interval [CI]:3.7%-8.3%) in Kapoeta South, 7.4% (CI:5.1%-10.7%) in Budi, 12.3% (CI:7.8%-18.9%) in Kapoeta East, and 18.1% (CI:13.5%-24.0%) in Kapoeta North. Trachomatous inflammation-intense prevalence among children ages 1-9 years ranged from 0.4% (CI:0.2%-1.0%) in Kapoeta East to 2.1% (CI:1.4%-3.2%) in Kapoeta North, and trachomatous trichiasis in individuals ages ≥15 years ranged from 1.0% (CI:0.5%-2.1%) in Kapoeta North to 1.9% (CI:1.3%-2.8%) in Budi.</p><p><strong>Conclusions: </strong>As no county reached the WHO elimination thresholds of trachomatous-inflammation follicular <5% or trachomatous trichiasis <0.2%, SAFE interventions should continue. Furthermore, these districts are classified as having persistent trachoma, based on trachomatous-inflammation follicular levels remaining >5% after two impact surveys. Compared to results from 2015, the prevalence of trachomatous-inflammation follicular, trachomatous inflammation-intense, and trachomatous trichiasis in all counties decreased, indicating that the Republic of South Sudan Ministry of Health's Trachoma Control Program is advancing towards its elimination goal.</p>","PeriodicalId":23962,"journal":{"name":"Tropical Medicine & International Health","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142955773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ismael Alves Rodrigues Júnior, Ana Thereza Chaves, Luciana Cardoso de Andrade, Sandra Lyon, Maria Aparecida de Faria Grossi, Ramayana Morais de Medeiros Brito, Ana Laura Grossi de Oliveira, Manoel de Figueiredo Villarroel, Manoel Otávio da Costa Rocha
Objectives: The purpose of this study was to determine reference points for thermal perception in cutaneous lesions of leprosy, a disease caused by Mycobacterium leprae characterised by hypoesthesia in skin lesions due to nerve and Schwann cell infection. Early diagnosis is essential to control transmission and effectively treat the disease.
Methods: Quantitative thermal testing (QTT) has been proposed as a valuable tool for early detection of the disease, initiation of treatment, and monitoring of nerve damage. A thermal analyser was used to determine warm and cold perception thresholds (WPT and CPT, respectively) in skin lesions of 42 leprosy patients and 22 healthy controls.
Results: The thresholds were determined using a 0.25 cm2 thermal stimulator, the method of limits, and the receiver operating characteristic (ROC) curve. Thermal thresholds were higher in patients' skin lesions compared to unaffected areas and controls. The reference points calculated for the WPT and CPT were 36.55 and 26.35°C, respectively, with high sensitivity and specificity.
Conclusion: The nerve fibres affected by leprosy caused altered thermal sensitivity in the patients' lesions, especially in warm sensation. A smaller thermal stimulator and the method of limits were effective in detecting early sensory deficits in nerve fibres, demonstrating the potential for early detection of the disease.
{"title":"Detection of sensory deficits in fine nerve fibres in leprosy diagnosis.","authors":"Ismael Alves Rodrigues Júnior, Ana Thereza Chaves, Luciana Cardoso de Andrade, Sandra Lyon, Maria Aparecida de Faria Grossi, Ramayana Morais de Medeiros Brito, Ana Laura Grossi de Oliveira, Manoel de Figueiredo Villarroel, Manoel Otávio da Costa Rocha","doi":"10.1111/tmi.14079","DOIUrl":"https://doi.org/10.1111/tmi.14079","url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of this study was to determine reference points for thermal perception in cutaneous lesions of leprosy, a disease caused by Mycobacterium leprae characterised by hypoesthesia in skin lesions due to nerve and Schwann cell infection. Early diagnosis is essential to control transmission and effectively treat the disease.</p><p><strong>Methods: </strong>Quantitative thermal testing (QTT) has been proposed as a valuable tool for early detection of the disease, initiation of treatment, and monitoring of nerve damage. A thermal analyser was used to determine warm and cold perception thresholds (WPT and CPT, respectively) in skin lesions of 42 leprosy patients and 22 healthy controls.</p><p><strong>Results: </strong>The thresholds were determined using a 0.25 cm<sup>2</sup> thermal stimulator, the method of limits, and the receiver operating characteristic (ROC) curve. Thermal thresholds were higher in patients' skin lesions compared to unaffected areas and controls. The reference points calculated for the WPT and CPT were 36.55 and 26.35°C, respectively, with high sensitivity and specificity.</p><p><strong>Conclusion: </strong>The nerve fibres affected by leprosy caused altered thermal sensitivity in the patients' lesions, especially in warm sensation. A smaller thermal stimulator and the method of limits were effective in detecting early sensory deficits in nerve fibres, demonstrating the potential for early detection of the disease.</p>","PeriodicalId":23962,"journal":{"name":"Tropical Medicine & International Health","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142955990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elichilia R Shao, Chee Wah Tan, Shailendra Mani, Danielle E Anderson, Bingileki F Lwezaula, Blandina T Mmbaga, Venance P Maro, Shu Shen, Fei Deng, Jo E B Halliday, Ângelo J Mendes, Deng B Madut, Sarah Cleaveland, John A Crump, Matthew P Rubach, Lin-Fa Wang
Background: Crimean-Congo hemorrhagic fever is a tick-borne zoonotic disease that may be severe and is present in many African countries. We aimed to understand the seroprevalence and risk for Crimean-Congo hemorrhagic fever virus in Tanzania by testing archived serum samples from patients enrolled in a prospective cohort study.
Methods: We prospectively enrolled febrile inpatients and outpatients from 2012 through 2014 at two referral hospitals in northern Tanzania. Archived serum samples were tested for Crimean-Congo hemorrhagic fever virus antibodies initially by a Luminex assay screen followed by confirmation with immunofluorescence assay. Evidence of exposure to Crimean-Congo hemorrhagic fever virus was defined as antibody detection by Luminex and confirmed by immunofluorescence assay. Questionnaire data were used to construct logistic regression models to understand factors associated with prior exposure to Crimean-Congo hemorrhagic fever virus. Domains of predictor variables included sociodemographics, livestock-rearing activities, and environmental factors.
Results: Of 735 participants included, antibodies to Crimean-Congo hemorrhagic fever virus nucleocapsid protein were detected by Luminex assay in 23 (3.1%) and confirmed by immunofluorescence assay in 13 (1.8%). In multivariable logistic regression, prior exposure to Crimean-Congo hemorrhagic fever virus was associated with self-report of milking livestock in the past month (adjusted OR [aOR]: 12.6, 95% CI 1.6-99.8) and natural log increase in goat density (head/km2; aOR: 1.7, 95% CI: 1.1-2.7).
Conclusions: We show serologic evidence of prior exposure to Crimean-Congo hemorrhagic fever virus among humans in northern Tanzania. Similar to other settings, our results suggest that exposure is closely linked to livestock activities. Additional research is warranted to understand reservoirs and modes of transmission of Crimean-Congo hemorrhagic fever virus to humans in northern Tanzania.
背景:克里米亚-刚果出血热是一种严重的蜱传人畜共患疾病,存在于许多非洲国家。我们的目的是通过检测一项前瞻性队列研究中登记的患者的存档血清样本,了解坦桑尼亚克里米亚-刚果出血热病毒的血清阳性率和风险。方法:我们前瞻性地招募了坦桑尼亚北部两家转诊医院2012年至2014年的发热住院和门诊患者。对存档的血清样本进行克里米亚-刚果出血热病毒抗体检测,最初采用Luminex试验筛选,然后采用免疫荧光试验确认。暴露于克里米亚-刚果出血热病毒的证据被定义为Luminex抗体检测并通过免疫荧光试验证实。问卷数据用于构建逻辑回归模型,以了解与既往接触克里米亚-刚果出血热病毒相关的因素。预测变量的领域包括社会人口统计学、家畜饲养活动和环境因素。结果:纳入的735名受试者中,23人(3.1%)通过Luminex法检测到克里米亚-刚果出血热病毒核衣壳蛋白抗体,13人(1.8%)通过免疫荧光法确认抗体。在多变量logistic回归中,先前暴露于克里米亚-刚果出血热病毒与过去一个月挤奶牲畜的自我报告相关(调整比值比[aOR]: 12.6, 95% CI 1.6-99.8),山羊密度的自然对数增长(头/平方公里;aOR: 1.7, 95% CI: 1.1-2.7)。结论:我们显示血清学证据表明,在坦桑尼亚北部的人类先前暴露于克里米亚-刚果出血热病毒。与其他环境类似,我们的结果表明,暴露与牲畜活动密切相关。有必要进行进一步研究,以了解坦桑尼亚北部克里米亚-刚果出血热病毒的宿主和传播方式。
{"title":"Seroprevalence and risk factors for Crimean-Congo hemorrhagic fever virus exposure among febrile patients in northern Tanzania.","authors":"Elichilia R Shao, Chee Wah Tan, Shailendra Mani, Danielle E Anderson, Bingileki F Lwezaula, Blandina T Mmbaga, Venance P Maro, Shu Shen, Fei Deng, Jo E B Halliday, Ângelo J Mendes, Deng B Madut, Sarah Cleaveland, John A Crump, Matthew P Rubach, Lin-Fa Wang","doi":"10.1111/tmi.14082","DOIUrl":"https://doi.org/10.1111/tmi.14082","url":null,"abstract":"<p><strong>Background: </strong>Crimean-Congo hemorrhagic fever is a tick-borne zoonotic disease that may be severe and is present in many African countries. We aimed to understand the seroprevalence and risk for Crimean-Congo hemorrhagic fever virus in Tanzania by testing archived serum samples from patients enrolled in a prospective cohort study.</p><p><strong>Methods: </strong>We prospectively enrolled febrile inpatients and outpatients from 2012 through 2014 at two referral hospitals in northern Tanzania. Archived serum samples were tested for Crimean-Congo hemorrhagic fever virus antibodies initially by a Luminex assay screen followed by confirmation with immunofluorescence assay. Evidence of exposure to Crimean-Congo hemorrhagic fever virus was defined as antibody detection by Luminex and confirmed by immunofluorescence assay. Questionnaire data were used to construct logistic regression models to understand factors associated with prior exposure to Crimean-Congo hemorrhagic fever virus. Domains of predictor variables included sociodemographics, livestock-rearing activities, and environmental factors.</p><p><strong>Results: </strong>Of 735 participants included, antibodies to Crimean-Congo hemorrhagic fever virus nucleocapsid protein were detected by Luminex assay in 23 (3.1%) and confirmed by immunofluorescence assay in 13 (1.8%). In multivariable logistic regression, prior exposure to Crimean-Congo hemorrhagic fever virus was associated with self-report of milking livestock in the past month (adjusted OR [aOR]: 12.6, 95% CI 1.6-99.8) and natural log increase in goat density (head/km<sup>2</sup>; aOR: 1.7, 95% CI: 1.1-2.7).</p><p><strong>Conclusions: </strong>We show serologic evidence of prior exposure to Crimean-Congo hemorrhagic fever virus among humans in northern Tanzania. Similar to other settings, our results suggest that exposure is closely linked to livestock activities. Additional research is warranted to understand reservoirs and modes of transmission of Crimean-Congo hemorrhagic fever virus to humans in northern Tanzania.</p>","PeriodicalId":23962,"journal":{"name":"Tropical Medicine & International Health","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-11-27DOI: 10.1111/tmi.14062
Muhammed O Afolabi, Dennis Adu-Gyasi, Lucy Paintain, Theresa Tawiah, Mohammed Sanni Ali, Brian Greenwood, Kwaku Poku Asante
Objectives: To evaluate the effectiveness and cost-effectiveness of integrating seasonal malaria chemoprevention (SMC) with mass drug administration for helminth control among school-aged children living in communities where the burden of malaria and helminths is high in Ghana, West Africa.
Methods: This cluster randomised controlled trial will enrol 1200 children aged 5-10 years. Eligible children randomised to intervention clusters will receive SMC drugs (sulphadoxine-pyrimethamine plus amodiaquine) and anthelminthic drugs for soil-transmitted helminths-(albendazole), and for schistosomiasis (praziquantel), while children randomised to control clusters will receive SMC drugs alone. Pre- and post-intervention blood, urine and stool samples will be collected from children in both clusters. The effectiveness of the concomitant delivery will be determined by checking whether the combination of SMC and anthelminthic drugs prevents anaemia in the children randomised to the intervention clusters compared to the children in the control clusters. Cost analysis and cost-effectiveness of this integrated delivery approach will be determined by estimating the incremental costs and effects of co-administration of SMC drugs with mass drug administration of anthelminthic drugs compared to SMC alone, including cost savings due to cases of moderate and severe anaemia averted.
Expected findings: The findings of this study will provide evidence to inform public health recommendations for an integrated control of malaria and helminths among children living in the poorest countries of the world.
{"title":"Evaluating the effectiveness and cost-effectiveness of integrating mass drug administration for helminth control with seasonal malaria chemoprevention in Ghanaian children: Protocol for a cluster randomised controlled trial.","authors":"Muhammed O Afolabi, Dennis Adu-Gyasi, Lucy Paintain, Theresa Tawiah, Mohammed Sanni Ali, Brian Greenwood, Kwaku Poku Asante","doi":"10.1111/tmi.14062","DOIUrl":"10.1111/tmi.14062","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the effectiveness and cost-effectiveness of integrating seasonal malaria chemoprevention (SMC) with mass drug administration for helminth control among school-aged children living in communities where the burden of malaria and helminths is high in Ghana, West Africa.</p><p><strong>Methods: </strong>This cluster randomised controlled trial will enrol 1200 children aged 5-10 years. Eligible children randomised to intervention clusters will receive SMC drugs (sulphadoxine-pyrimethamine plus amodiaquine) and anthelminthic drugs for soil-transmitted helminths-(albendazole), and for schistosomiasis (praziquantel), while children randomised to control clusters will receive SMC drugs alone. Pre- and post-intervention blood, urine and stool samples will be collected from children in both clusters. The effectiveness of the concomitant delivery will be determined by checking whether the combination of SMC and anthelminthic drugs prevents anaemia in the children randomised to the intervention clusters compared to the children in the control clusters. Cost analysis and cost-effectiveness of this integrated delivery approach will be determined by estimating the incremental costs and effects of co-administration of SMC drugs with mass drug administration of anthelminthic drugs compared to SMC alone, including cost savings due to cases of moderate and severe anaemia averted.</p><p><strong>Expected findings: </strong>The findings of this study will provide evidence to inform public health recommendations for an integrated control of malaria and helminths among children living in the poorest countries of the world.</p>","PeriodicalId":23962,"journal":{"name":"Tropical Medicine & International Health","volume":" ","pages":"22-30"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697521/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142733297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmed Adamu Gololo, Sajesh K Veettil, Puree Anantachoti, Suthira Taychakhoonavudh, Chanthawat Patikorn
Background: Epidemiological modelling studies in snakebite envenoming research are evolving. Their techniques can be essential in filling the knowledge gap needed to attain the World Health Organization's (WHO) goal of halving the burden of snakebite envenoming by complementing the current data scarcity. Hence, there is a need for a systematic review to summarise epidemiological models used in estimating the burden of snakebite envenoming.
Methods: We conducted a systematic review by searching PubMed, EMBASE, and Scopus to identify articles reporting epidemiological models in snakebite envenoming from database inception to 31st December 2023. A narrative synthesis was performed to summarise types of models, methodologies, input parameters, model outputs, and associating factors.
Results: Thirty-nine modelling studies were included from 2426 retrieved articles, comprising statistical models (76.9%) and mathematical models (23.1%). Most of the studies were conducted in South Asia, (35.9%) and Latin America (35.9%), and only a few (5.1%) were a global burden estimation. The eligible studies constructed 42 epidemiological models, of which 33 were statistical models that included regression, (60.6%) geostatistical (21.2%), and time series, (18.2%) while 9 mathematical models comprised compartmental, (44.4%) agent-based, (22.2%) transmission dynamics, (11.1%) network, (11.1%) and a simple mathematical model (11.1%). The outputs of the models varied across the study objectives. Statistical models analysed the relationship between incidence, (83.3%) mortality, (33.3%) morbidity (16.7%) and prevalence (10.0%) and their associating factors (environmental, [80%] socio-demographic [33.3%] and therapeutic [10.0%]). Mathematical models estimated incidence, (100%) mortality (33.3%), and morbidity (22.2%). Five mathematical modelling studies considered associating factors, including environmental (60%) and socio-demographic factors (40%).
Conclusion: Mathematical and statistical models are crucial for estimating the burden of snakebite envenoming, offering insights into risk prediction and resource allocation. Current challenges include low-quality data and methodological heterogeneity. Modelling studies are needed, and their continued improvement is vital for meeting WHO goals. Future research should emphasise standardised methodologies, high-quality community data, and stakeholder engagement to create accurate, applicable models for prevention and resource optimization in high-burden regions, including Africa and Asia.
{"title":"Epidemiological models to estimate the burden of snakebite envenoming: A systematic review.","authors":"Ahmed Adamu Gololo, Sajesh K Veettil, Puree Anantachoti, Suthira Taychakhoonavudh, Chanthawat Patikorn","doi":"10.1111/tmi.14080","DOIUrl":"https://doi.org/10.1111/tmi.14080","url":null,"abstract":"<p><strong>Background: </strong>Epidemiological modelling studies in snakebite envenoming research are evolving. Their techniques can be essential in filling the knowledge gap needed to attain the World Health Organization's (WHO) goal of halving the burden of snakebite envenoming by complementing the current data scarcity. Hence, there is a need for a systematic review to summarise epidemiological models used in estimating the burden of snakebite envenoming.</p><p><strong>Methods: </strong>We conducted a systematic review by searching PubMed, EMBASE, and Scopus to identify articles reporting epidemiological models in snakebite envenoming from database inception to 31st December 2023. A narrative synthesis was performed to summarise types of models, methodologies, input parameters, model outputs, and associating factors.</p><p><strong>Results: </strong>Thirty-nine modelling studies were included from 2426 retrieved articles, comprising statistical models (76.9%) and mathematical models (23.1%). Most of the studies were conducted in South Asia, (35.9%) and Latin America (35.9%), and only a few (5.1%) were a global burden estimation. The eligible studies constructed 42 epidemiological models, of which 33 were statistical models that included regression, (60.6%) geostatistical (21.2%), and time series, (18.2%) while 9 mathematical models comprised compartmental, (44.4%) agent-based, (22.2%) transmission dynamics, (11.1%) network, (11.1%) and a simple mathematical model (11.1%). The outputs of the models varied across the study objectives. Statistical models analysed the relationship between incidence, (83.3%) mortality, (33.3%) morbidity (16.7%) and prevalence (10.0%) and their associating factors (environmental, [80%] socio-demographic [33.3%] and therapeutic [10.0%]). Mathematical models estimated incidence, (100%) mortality (33.3%), and morbidity (22.2%). Five mathematical modelling studies considered associating factors, including environmental (60%) and socio-demographic factors (40%).</p><p><strong>Conclusion: </strong>Mathematical and statistical models are crucial for estimating the burden of snakebite envenoming, offering insights into risk prediction and resource allocation. Current challenges include low-quality data and methodological heterogeneity. Modelling studies are needed, and their continued improvement is vital for meeting WHO goals. Future research should emphasise standardised methodologies, high-quality community data, and stakeholder engagement to create accurate, applicable models for prevention and resource optimization in high-burden regions, including Africa and Asia.</p>","PeriodicalId":23962,"journal":{"name":"Tropical Medicine & International Health","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-12-04DOI: 10.1111/tmi.14067
Giacomo Rotini, Axel de Mangou, Agathe Combe, Amelie Renou, Chloe Combe, Radj Cally, Marie Lagrange-Xelot, Nicolas Allou, Guillaume Miltgen, Charles Vidal
Acinetobacter baumannii (Ab) has emerged in the last decades as a cause of community-acquired pneumonia (CAP) in tropical and subtropical regions. We previously conducted the first investigation on this topic in France with a case series of severe CAP-Ab in Reunion Island over an eight-year period. In the present work, we aim to highlight the specific aspects of CAP-Ab by comparing our case series with an historical cohort (PAC_RUN), obtained by retrospective chart review (2016-2021) of severe community-acquired pneumonia cases on Reunion Island, in which CAP-Ab was ruled out. During the study period, eight CAP-Ab cases were identified, giving an incidence of 0.1 cases per 100,000 people/year, and an incidence of 16.5 cases per 100,000 people/year for non-Ab-related CAP (n = 761). By comparing with non-Ab-related CAP, patients had more excessive alcohol use (75% vs. 25.6%, p = 0.005) and lower body mass index (21 vs. 24 kg/m2, p = 0.004). Six cases (75%) of CAP-Ab occurred during the rainy season (p = 0.06). Mortality was higher (62.5% vs. 24.3%, p = 0.02) and time to death was shorter (median 2 days vs. 7, p = 0.009) in the CAP-Ab group. Bacteraemic pneumonia was strongly associated with CAP-Ab (62.5% vs. 15.7%, p = 0.004). Significant differences were found in the need for renal replacement therapy (75% vs. 17.2%, p < 0.001), catecholamine use (100% vs. 54.5%, p = 0.01) and use of invasive mechanical ventilation (100% vs. 62.7%, p = 0.03). Also, in the proportion of severe acute respiratory distress syndrome (62.5% vs. 23.2%, p = 0.02), septic shock (100% vs. 40.6%, p < 0.001), and cardiogenic shock (87.5% vs. 15.9%, p < 0.001). Compared to severe non-Ab-related CAP, severe CAP-Ab is characterised by higher mortality, associated with a high frequency of multiple organ failure. Excessive alcohol consumption and malnutrition seem to be risk factors. To improve outcomes, broader spectrum antibiotic therapy must be immediately proposed when CAP-Ab is suspected.
鲍曼不动杆菌(Ab)在过去几十年中作为热带和亚热带地区社区获得性肺炎(CAP)的原因出现。我们之前在法国对留尼旺岛8年期间的一系列严重CAP-Ab病例进行了关于这一主题的首次调查。在目前的工作中,我们的目标是通过将我们的病例系列与留尼旺岛严重社区获得性肺炎病例的回顾性图表回顾(2016-2021)获得的历史队列(PAC_RUN)进行比较,以突出CAP-Ab的具体方面,其中CAP-Ab被排除在外。在研究期间,确定了8例CAP- ab病例,发病率为每10万人/年0.1例,非ab相关的CAP发病率为每10万人/年16.5例(n = 761)。与非ab相关的CAP相比,患者有更多的过度饮酒(75%对25.6%,p = 0.005)和较低的体重指数(21对24 kg/m2, p = 0.004)。6例(75%)CAP-Ab发生在雨季(p = 0.06)。CAP-Ab组的死亡率更高(62.5%比24.3%,p = 0.02),死亡时间更短(中位2天比7天,p = 0.009)。细菌性肺炎与CAP-Ab密切相关(62.5%比15.7%,p = 0.004)。两组在肾脏替代治疗需求方面存在显著差异(75% vs. 17.2%, p
{"title":"Severe community-acquired pneumonia compared to severe community-acquired Acinetobacter baumannii pneumonia in Reunion Island: A retrospective study.","authors":"Giacomo Rotini, Axel de Mangou, Agathe Combe, Amelie Renou, Chloe Combe, Radj Cally, Marie Lagrange-Xelot, Nicolas Allou, Guillaume Miltgen, Charles Vidal","doi":"10.1111/tmi.14067","DOIUrl":"10.1111/tmi.14067","url":null,"abstract":"<p><p>Acinetobacter baumannii (Ab) has emerged in the last decades as a cause of community-acquired pneumonia (CAP) in tropical and subtropical regions. We previously conducted the first investigation on this topic in France with a case series of severe CAP-Ab in Reunion Island over an eight-year period. In the present work, we aim to highlight the specific aspects of CAP-Ab by comparing our case series with an historical cohort (PAC_RUN), obtained by retrospective chart review (2016-2021) of severe community-acquired pneumonia cases on Reunion Island, in which CAP-Ab was ruled out. During the study period, eight CAP-Ab cases were identified, giving an incidence of 0.1 cases per 100,000 people/year, and an incidence of 16.5 cases per 100,000 people/year for non-Ab-related CAP (n = 761). By comparing with non-Ab-related CAP, patients had more excessive alcohol use (75% vs. 25.6%, p = 0.005) and lower body mass index (21 vs. 24 kg/m<sup>2</sup>, p = 0.004). Six cases (75%) of CAP-Ab occurred during the rainy season (p = 0.06). Mortality was higher (62.5% vs. 24.3%, p = 0.02) and time to death was shorter (median 2 days vs. 7, p = 0.009) in the CAP-Ab group. Bacteraemic pneumonia was strongly associated with CAP-Ab (62.5% vs. 15.7%, p = 0.004). Significant differences were found in the need for renal replacement therapy (75% vs. 17.2%, p < 0.001), catecholamine use (100% vs. 54.5%, p = 0.01) and use of invasive mechanical ventilation (100% vs. 62.7%, p = 0.03). Also, in the proportion of severe acute respiratory distress syndrome (62.5% vs. 23.2%, p = 0.02), septic shock (100% vs. 40.6%, p < 0.001), and cardiogenic shock (87.5% vs. 15.9%, p < 0.001). Compared to severe non-Ab-related CAP, severe CAP-Ab is characterised by higher mortality, associated with a high frequency of multiple organ failure. Excessive alcohol consumption and malnutrition seem to be risk factors. To improve outcomes, broader spectrum antibiotic therapy must be immediately proposed when CAP-Ab is suspected.</p>","PeriodicalId":23962,"journal":{"name":"Tropical Medicine & International Health","volume":" ","pages":"43-50"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Implementation studies indicate that the addition of tuberculosis diagnosis and treatment services into the community health extension workers' tasks-that is 'task-shifting'-improved case detection and treatment outcomes in Ethiopia. Given resource and operational constraints, only a limited number of areas can be targeted by an expanded task-shifting program. Therefore, we mapped the distributional disparities in tuberculosis services across regions and districts and modelled the equity pathways towards optimising national scale-up of this task-shifting intervention in Ethiopia.
Methods: We used data from various sources including District Health Information Software 2; demographic, geospatial and topographic data; and previously published implementation study findings. We developed methods to integrate these datasets and to calculate the proportion of health facilities with tuberculosis services, the district population to health centre ratio, and the proportion of district population living within 2h walking distance from a health centre. Equity and disparities were then measured in terms of: tuberculosis services coverage; health centre adequacy, that is the district population served by health centres; and spatial access adequacy, that is the district population with health centre access within a two-hour walking distance. Subsequently, districts were ranked according to these measures to allow prioritisation of the health extension worker task-shifting intervention.
Results: Tuberculosis services coverage varied from 54% in Afar region to 100% in Harari region, and health centre inadequacy ranged from 10% of districts in Benishangul-Gumuz to 87% in Sidama. After spatial access adjustment, health centre inadequacy ranged from 7% of districts in Sidama to 91% in Somali; and tuberculosis services inadequacy from 7% of districts in Sidama to 97% in Afar. Task-shifting implemented in inadequate districts (55% of all districts) could raise national case detection rate from 66% (currently) to 88% and treatment success rate from 93% to 99%; Benishangul-Gumuz achieving the largest increase of all regions.
Conclusions: Access to effective tuberculosis services presents substantial disparities across districts in Ethiopia, due to both health system and tuberculosis-specific factors. Jointly considering both types of factors would enable prioritisation of districts where health extension workers would be most impactful.
{"title":"Inequalities in tuberculosis control in Ethiopia: A district-level distributional modelling analysis.","authors":"Fentabil Getnet, Tom Forzy, Latera Tesfaye, Awoke Misganaw, Solomon Tessema Memirie, Shewayiref Geremew, Tezera Moshago Berheto, Naod Wendrad, Bantalem Yeshanew Yihun, Mizan Kiros Mirutse, Fasil Tsegaye, Mesay Hailu Dangisso, Stéphane Verguet","doi":"10.1111/tmi.14066","DOIUrl":"10.1111/tmi.14066","url":null,"abstract":"<p><strong>Background: </strong>Implementation studies indicate that the addition of tuberculosis diagnosis and treatment services into the community health extension workers' tasks-that is 'task-shifting'-improved case detection and treatment outcomes in Ethiopia. Given resource and operational constraints, only a limited number of areas can be targeted by an expanded task-shifting program. Therefore, we mapped the distributional disparities in tuberculosis services across regions and districts and modelled the equity pathways towards optimising national scale-up of this task-shifting intervention in Ethiopia.</p><p><strong>Methods: </strong>We used data from various sources including District Health Information Software 2; demographic, geospatial and topographic data; and previously published implementation study findings. We developed methods to integrate these datasets and to calculate the proportion of health facilities with tuberculosis services, the district population to health centre ratio, and the proportion of district population living within 2h walking distance from a health centre. Equity and disparities were then measured in terms of: tuberculosis services coverage; health centre adequacy, that is the district population served by health centres; and spatial access adequacy, that is the district population with health centre access within a two-hour walking distance. Subsequently, districts were ranked according to these measures to allow prioritisation of the health extension worker task-shifting intervention.</p><p><strong>Results: </strong>Tuberculosis services coverage varied from 54% in Afar region to 100% in Harari region, and health centre inadequacy ranged from 10% of districts in Benishangul-Gumuz to 87% in Sidama. After spatial access adjustment, health centre inadequacy ranged from 7% of districts in Sidama to 91% in Somali; and tuberculosis services inadequacy from 7% of districts in Sidama to 97% in Afar. Task-shifting implemented in inadequate districts (55% of all districts) could raise national case detection rate from 66% (currently) to 88% and treatment success rate from 93% to 99%; Benishangul-Gumuz achieving the largest increase of all regions.</p><p><strong>Conclusions: </strong>Access to effective tuberculosis services presents substantial disparities across districts in Ethiopia, due to both health system and tuberculosis-specific factors. Jointly considering both types of factors would enable prioritisation of districts where health extension workers would be most impactful.</p>","PeriodicalId":23962,"journal":{"name":"Tropical Medicine & International Health","volume":" ","pages":"31-42"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-12-01DOI: 10.1111/tmi.14061
Susannah Colt, Andrew Edielu, David Lewander, Hannah W Wu, Emily L Webb, Patrice A Mawa, Racheal Nakyesige, A Gloria K Ayebazibwe, Jennifer F Friedman, Amaya L Bustinduy
Background: Environmental enteric dysfunction (EED) is an acquired subclinical condition of the small intestine with lasting health implications for nutritional status, linear growth and development among children. EED is characterised by structural and functional changes to the gut barrier. There are no standardised diagnostic criteria, however, a number of biomarkers have been evaluated to capture EED domains. While the causes of EED are not fully understood, risk factors include poor water, sanitation and hygiene conditions and exposure to enteric pathogens. Very few studies have evaluated the impact of schistosomiasis on EED despite repeated intestinal damage from parasite eggs passing across the gut barrier.
Methods: In a cohort of 354 preschool-aged children aged 12-47 months with Schistosoma mansoni infection recruited from the Lake Albert region of Uganda, we assessed exposure to water, sanitation and hygiene conditions and measured markers from each EED domain: intestinal inflammation (faecal calprotectin), epithelial damage (serum intestinal fatty-acid binding-protein), increased permeability (urine lactulose to mannitol ratio and faecal alpha-1 antitrypsin) and microbial translocation (serum endotoxin core antibody).
Results: In multivariable linear regression models, we found that children whose drinking water was sourced from Lake Albert had higher concentrations of intestinal fatty-acid binding-protein (β = 0.48, 95% CI 0.20-0.76, p < 0.001), and lack of toilet/latrine access was associated with higher concentrations of calprotectin (β = 0.48, 95% CI 0.18-0.78, p < 0.01). Higher schistosomiasis intensity (eggs per gram of stool) was associated with higher calprotectin (β = 0.10, 95% CI 0.02-0.17, p = 0.01), but not with other EED markers.
Conclusions: Few studies have investigated schistosomiasis-related morbidities in very young children infected with schistosomiasis. Our findings from Uganda show that poor water, sanitation and hygiene conditions and heavier schistosomiasis burden are associated with intestinal inflammation and damage, contributing to EED. Improved treatment coverage for preschool-aged children infected with schistosomiasis may reduce the burden from EED and associated long-term morbidities.
背景:环境性肠功能障碍(EED)是一种获得性小肠亚临床状况,对儿童的营养状况、线性生长和发育具有持久的健康影响。EED的特点是肠道屏障的结构和功能改变。目前还没有标准化的诊断标准,但是已经评估了一些生物标志物来捕获EED结构域。虽然导致EED的原因还不完全清楚,但危险因素包括水、环境卫生和个人卫生条件差以及接触肠道病原体。很少有研究评估血吸虫病对EED的影响,尽管寄生虫卵通过肠道屏障反复造成肠道损伤。方法:从乌干达艾伯特湖地区招募了354名12-47个月感染曼氏血吸虫的学龄前儿童,我们评估了接触水、环境卫生和卫生条件,并测量了每个EED结构域的标记物。肠道炎症(粪便钙保护蛋白),上皮损伤(血清肠道脂肪酸结合蛋白),渗透性增加(尿乳果糖与甘露醇比和粪便α -1抗胰蛋白酶)和微生物易位(血清内毒素核心抗体)。结果:在多变量线性回归模型中,我们发现饮用来自艾伯特湖的水的儿童肠道脂肪酸结合蛋白浓度较高(β = 0.48, 95% CI 0.20-0.76, p)。结论:很少有研究调查极年幼感染血吸虫病的儿童与血吸虫病相关的发病率。我们在乌干达的研究结果表明,不良的水、环境卫生和个人卫生条件以及较重的血吸虫病负担与肠道炎症和损伤有关,从而导致肠内感染。提高对感染血吸虫病的学龄前儿童的治疗覆盖率,可能会减少急性病的负担和相关的长期发病率。
{"title":"Associations of poor water, sanitation, and hygiene and parasite burden with markers of environmental enteric dysfunction in preschool-age children infected with Schistosoma mansoni in Uganda.","authors":"Susannah Colt, Andrew Edielu, David Lewander, Hannah W Wu, Emily L Webb, Patrice A Mawa, Racheal Nakyesige, A Gloria K Ayebazibwe, Jennifer F Friedman, Amaya L Bustinduy","doi":"10.1111/tmi.14061","DOIUrl":"10.1111/tmi.14061","url":null,"abstract":"<p><strong>Background: </strong>Environmental enteric dysfunction (EED) is an acquired subclinical condition of the small intestine with lasting health implications for nutritional status, linear growth and development among children. EED is characterised by structural and functional changes to the gut barrier. There are no standardised diagnostic criteria, however, a number of biomarkers have been evaluated to capture EED domains. While the causes of EED are not fully understood, risk factors include poor water, sanitation and hygiene conditions and exposure to enteric pathogens. Very few studies have evaluated the impact of schistosomiasis on EED despite repeated intestinal damage from parasite eggs passing across the gut barrier.</p><p><strong>Methods: </strong>In a cohort of 354 preschool-aged children aged 12-47 months with Schistosoma mansoni infection recruited from the Lake Albert region of Uganda, we assessed exposure to water, sanitation and hygiene conditions and measured markers from each EED domain: intestinal inflammation (faecal calprotectin), epithelial damage (serum intestinal fatty-acid binding-protein), increased permeability (urine lactulose to mannitol ratio and faecal alpha-1 antitrypsin) and microbial translocation (serum endotoxin core antibody).</p><p><strong>Results: </strong>In multivariable linear regression models, we found that children whose drinking water was sourced from Lake Albert had higher concentrations of intestinal fatty-acid binding-protein (β = 0.48, 95% CI 0.20-0.76, p < 0.001), and lack of toilet/latrine access was associated with higher concentrations of calprotectin (β = 0.48, 95% CI 0.18-0.78, p < 0.01). Higher schistosomiasis intensity (eggs per gram of stool) was associated with higher calprotectin (β = 0.10, 95% CI 0.02-0.17, p = 0.01), but not with other EED markers.</p><p><strong>Conclusions: </strong>Few studies have investigated schistosomiasis-related morbidities in very young children infected with schistosomiasis. Our findings from Uganda show that poor water, sanitation and hygiene conditions and heavier schistosomiasis burden are associated with intestinal inflammation and damage, contributing to EED. Improved treatment coverage for preschool-aged children infected with schistosomiasis may reduce the burden from EED and associated long-term morbidities.</p>","PeriodicalId":23962,"journal":{"name":"Tropical Medicine & International Health","volume":" ","pages":"14-21"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}